共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R026175-1mg | 1mg | 5~7个工作日 |
4,5-二氢-n,1,4,4-四甲基-8-[[4-(4-... PHA-848125 |
99% |
|
|
阿拉丁 | P127815-5mg | 5mg | 现货 |
PHA-848125,ATP竞争性CDK2和TRKA抑制... PHA-848125 |
Moligand™, ≥98% |
|
|
阿拉丁 | P127815-10mg | 10mg | 现货 |
PHA-848125,ATP竞争性CDK2和TRKA抑制... PHA-848125 |
Moligand™, ≥98% |
|
|
阿拉丁 | P127815-50mg | 50mg | 现货 |
PHA-848125,ATP竞争性CDK2和TRKA抑制... PHA-848125 |
Moligand™, ≥98% |
|
|
阿拉丁 | P127815-1mg | 1mg | 现货 |
PHA-848125,ATP竞争性CDK2和TRKA抑制... PHA-848125 |
Moligand™, ≥98% |
|
|
阿拉丁 | M409217-1ml | 1ml | 现货 |
Milciclib (PHA-848125) Milciclib (PHA-848125) |
Moligand™, 10mM in DMSO |
|
|
凯为 | JZ00G4PL-10mg | 10mg | 期货,请咨询 |
4,5-二氢-n,1,4,4-四甲基-8-[[4-(4-... PHA-848125 |
98+% |
|
|
凯为 | JZ00G4PL-25mg | 25mg | 期货,请咨询 |
4,5-二氢-n,1,4,4-四甲基-8-[[4-(4-... PHA-848125 |
98+% |
|
|
凯为 | JZ00G4PL-50mg | 50mg | 期货,请咨询 |
4,5-二氢-n,1,4,4-四甲基-8-[[4-(4-... PHA-848125 |
98+% |
|
|
凯为 | JZ00G4PL-100mg | 100mg | 期货,请咨询 |
4,5-二氢-n,1,4,4-四甲基-8-[[4-(4-... PHA-848125 |
98+% |
|
|
凯为 | JZ00G4PL-250mg | 250mg | 期货,请咨询 |
4,5-二氢-n,1,4,4-四甲基-8-[[4-(4-... PHA-848125 |
98+% |
|
|
凯为 | JZ00G4PL-1mg | 1mg | 期货,请咨询 |
4,5-二氢-n,1,4,4-四甲基-8-[[4-(4-... PHA-848125 |
98+% |
|
|
凯为 | JZ00G4PL-5mg | 5mg | 期货,请咨询 |
4,5-二氢-n,1,4,4-四甲基-8-[[4-(4-... PHA-848125 |
98+% |
|
|
毕得 | BD211339-5mg | 5mg | 现货 |
N,1,4,4-四甲基-8-((4-(4-甲基哌嗪-1-... N,1,4,4-Tetramethyl-8-((4-(4... |
98+% |
|
|
毕得 | BD211339-10mg | 10mg | 现货 |
N,1,4,4-四甲基-8-((4-(4-甲基哌嗪-1-... N,1,4,4-Tetramethyl-8-((4-(4... |
98+% |
|
|
毕得 | BD211339-50mg | 50mg | 现货 |
N,1,4,4-四甲基-8-((4-(4-甲基哌嗪-1-... N,1,4,4-Tetramethyl-8-((4-(4... |
98+% |
|
|
毕得 | BD211339-1mg | 1mg | 现货 |
N,1,4,4-四甲基-8-((4-(4-甲基哌嗪-1-... N,1,4,4-Tetramethyl-8-((4-(4... |
98+% |
|
|
毕得 | BD211339-25mg | 25mg | 现货 |
N,1,4,4-四甲基-8-((4-(4-甲基哌嗪-1-... N,1,4,4-Tetramethyl-8-((4-(4... |
98+% |
|
|
毕得 | BD211339-100mg | 100mg | 现货 |
N,1,4,4-四甲基-8-((4-(4-甲基哌嗪-1-... N,1,4,4-Tetramethyl-8-((4-(4... |
98+% |
|
|
毕得 | BD211339-250mg | 250mg | 现货 |
N,1,4,4-四甲基-8-((4-(4-甲基哌嗪-1-... N,1,4,4-Tetramethyl-8-((4-(4... |
98+% |
|
|
源叶 | S80959-1mg | 1mg | 现货 |
PHA-848125 PHA-848125 |
98% |
|
|
源叶 | S80959-5mg | 5mg | 现货 |
PHA-848125 PHA-848125 |
98% |
|
|
源叶 | S80959-10mg | 10mg | 现货 |
PHA-848125 PHA-848125 |
98% |
|
|
源叶 | S80959-50mg | 50mg | 现货 |
PHA-848125 PHA-848125 |
98% |
|
|
源叶 | T94426-1ml | 1ml | 期货,请咨询 |
Milciclib (PHA-848125) Milciclib (PHA-848125) |
10mM in DMSO |
|
|
Target Mol | T6081-1mg | 1mg | 现货 |
化合物 Milciclib Milcicli |
99.73% |
|
|
Target Mol | T6081-5mg | 5mg | 现货 |
化合物 Milciclib Milcicli |
99.73% |
|
|
Target Mol | T6081-10mg | 10mg | 现货 |
化合物 Milciclib Milcicli |
99.73% |
|
|
Target Mol | T6081-25mg | 25mg | 现货 |
化合物 Milciclib Milcicli |
99.73% |
|
|
Target Mol | T6081-50mg | 50mg | 现货 |
化合物 Milciclib Milcicli |
99.73% |
|
|
Target Mol | T6081-100mg | 100mg | 现货 |
化合物 Milciclib Milcicli |
99.73% |
|
|
Target Mol | T6081-200mg | 200mg | 现货 |
化合物 Milciclib Milcicli |
99.73% |
|
|
Target Mol | T6081-1mL | 1mL | 现货 |
化合物 Milciclib Milcicli |
99.73% |
|
|
Am | A127625-50mg | 50mg | 现货 |
Milciclib Milcicli |
98+% |
|
|
Am | A127625-10mg | 10mg | 现货 |
Milciclib Milcicli |
98+% |
|
|
Am | A127625-1mg | 1mg | 现货 |
Milciclib Milcicli |
98+% |
|
|
Am | A127625-25mg | 25mg | 现货 |
Milciclib Milcicli |
98+% |
|
|
Am | A127625-5mg | 5mg | 现货 |
Milciclib Milcicli |
98+% |
|
|
MCE | HY-10424-100mg | 100mg | 现货 |
Milciclib Milcicli |
99.90% |
|
|
MCE | HY-10424-50mg | 50mg | 现货 |
Milciclib Milcicli |
99.90% |
|
|
MCE | HY-10424-25mg | 25mg | 现货 |
Milciclib Milcicli |
99.90% |
|
|
MCE | HY-10424-10mg | 10mg | 现货 |
Milciclib Milcicli |
99.90% |
|
|
MCE | HY-10424-10mM*1mL | 10mM*1mL | 现货 |
Milciclib Milcicli |
99.90% |
|
|
MCE | HY-10424-5mg | 5mg | 现货 |
Milciclib Milcicli |
99.90% |
|
|
MCE | HY-10424-1mg | 1mg | 现货 |
Milciclib Milcicli |
99.90% |
|
|